MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
874.52%
Quick Ratio
874.52%
Cash Ratio
171.42%
Debt to Asset Ratio
15.42%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Intangible assets, in-process re...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Deferred income (note 3)
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
53,972 30,629 26,762 28,849
Short-term investments
216,957 114,108 147,375 162,729
Accounts receivable, net (allowance for doubtful accounts was 375 for each period)
58 6 179 225
Prepaid expenses and other current assets
4,365 3,646 4,184 4,155
Total current assets
275,352 148,389 178,500 195,958
Property and equipment, gross
99,811 82,801 69,546 NaN
Less accumulated depreciation
7,328 6,204 5,195 NaN
Property and equipment, net
92,483 76,597 64,351 62,599
Right-of-use asset, net
2,444 1,500 1,536 1,767
Restricted cash
NaN NaN NaN 0
Intangible assets, in-process research and development
40,000 40,000 50,000 50,000
Other assets, net
490 486 438 401
Total assets
410,769 266,972 294,825 310,725
Deferred income (note 3)
NaN 0 0 0
Accounts payable and accrued expenses
26,485 20,511 13,148 7,048
Lease liability
1,069 623 704 847
Accrued personnel expenses
3,876 7,489 6,711 5,037
Note payable
56 56 55 54
Total current liabilities
31,486 28,679 20,618 12,986
Lease liability, net of current portion
1,552 1,005 971 1,071
Note payable, net of current portion
1,554 1,569 1,583 1,597
Deferred income (note 3)
26,600 26,600 26,600 26,600
Deferred tax liability
1,702 1,702 2,495 2,495
Other noncurrent liabilities
437 386 342 284
Total liabilities
63,331 59,941 52,609 45,033
Common stock 0.001 par value 750,000,000 shares authorized 114,017,755 and 74,337,990 shares issued
114 74 74 74
Additional paid-in capital
708,579 541,687 539,378 536,996
Accumulated other comprehensive (loss) income
-226 110 114 3
Accumulated deficit
-361,029 -334,840 -297,350 -271,381
Total stockholders' equity
347,438 207,031 242,216 265,692
Total liabilities and stockholders' equity
410,769 266,972 294,825 310,725
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$216,957K Cash and cashequivalents$53,972K Prepaid expenses andother current assets$4,365K Accounts receivable, net(allowance for doubtful...$58K Property and equipment,gross$99,811K Total current assets$275,352K Property and equipment,net$92,483K Intangible assets,in-process research and...$40,000K Right-of-use asset, net$2,444K Other assets, net$490K Less accumulateddepreciation$7,328K Total assets$410,769K Total liabilities andstockholders' equity$410,769K Total stockholders'equity$347,438K Total liabilities$63,331K Accumulated deficit-$361,029K Accumulated othercomprehensive (loss) income-$226K Additional paid-in capital$708,579K Total currentliabilities$31,486K Deferred income (note 3)$26,600K Deferred tax liability$1,702K Note payable, net ofcurrent portion$1,554K Lease liability, netof current portion$1,552K Other noncurrentliabilities$437K Common stock 0.001 parvalue 750,000,000...$114K Accounts payable andaccrued expenses$26,485K Accrued personnelexpenses$3,876K Lease liability$1,069K Note payable$56K

Perspective Therapeutics, Inc. (CATX)

Perspective Therapeutics, Inc. (CATX)